DeepMed Research

University of Kansas Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1906-01-01

Employees: 5K

Market Cap: -

Website: https://www.kumc.edu

Clinical Trials

Atrial Fibrillation Detection Using Garmin Wearable Technology

Conditions: Atrial Fibrillation

Interventions: Device: Garmin Smart Watch
Device: Garmin Chest Band

First Posted Date: 2018-06-25

Last Posted Date: 2019-09-04

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 120

Registration Number: NCT03566836

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial

Phase 2

Active, not recruiting

Conditions: Pancreatic Cancer

Interventions: Drug: Niraparib Treatment

First Posted Date: 2018-06-12

Last Posted Date: 2023-05-19

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 18

Registration Number: NCT03553004

Locations: 🇺🇸
University of Kansas Cancer Center - Overland Park, Overland Park, Kansas, United States
🇺🇸
University of Kansas Cancer Center - Clinical Research Center, Fairway, Kansas, United States
🇺🇸
The University of Kansas Cancer Center, Westwood, Kansas, United States

and more 3 locations

Examining Effects of Aerobic Exercise on Pain Sensation

Not Applicable

Completed

Conditions: Chronic Low Back Pain

Interventions: Behavioral: Aerobic exercise program

First Posted Date: 2018-06-06

Last Posted Date: 2019-09-27

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 10

Registration Number: NCT03546153

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Phase 1

Recruiting

Conditions: Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Chronic Myeloid Leukemia
Myelodysplastic Syndromes

Interventions: Drug: EAGD T-cell infusion (Phase I)
Drug: EAGD T-cell infusion (Expansion)

First Posted Date: 2018-05-23

Last Posted Date: 2023-02-08

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 38

Registration Number: NCT03533816

Locations: 🇺🇸
University of Kansas Cancer Center, Westwood, Kansas, United States

Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery

Phase 3

Completed

Conditions: Burns

Interventions: Drug: Sugammadex
Drug: Neostigmine
Drug: Glycopyrrolate

First Posted Date: 2018-05-01

Last Posted Date: 2023-09-28

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 7

Registration Number: NCT03513406

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Physical Activity Across the Curriculum (PAAC 3):Teacher vs. Remotely Delivered Classroom Physical Activity Breaks

Not Applicable

Completed

Conditions: Physical Activity

Interventions: Behavioral: Physical Activity Across the Curriculum

First Posted Date: 2018-04-10

Last Posted Date: 2024-08-21

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 470

Registration Number: NCT03493139

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Innovative Pulmonary Rehabilitation Telehealth Program for Improving COPD Patient Outcomes

Not Applicable

Completed

Conditions: COPD

Interventions: Behavioral: Telehealth Program

First Posted Date: 2018-04-05

Last Posted Date: 2021-03-05

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 12

Registration Number: NCT03489642

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

Phase 2

Active, not recruiting

Conditions: Gastro Esophageal Junction Cancer
Stomach Cancer
Adenocarcinoma

Interventions: Drug: Neoadjuvant Treatment - mFOLFOX6 & Pembrolizumab
Drug: Adjuvant Treatment - mFOLFOX & Pembrolizumab

First Posted Date: 2018-04-05

Last Posted Date: 2023-05-19

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 40

Registration Number: NCT03488667

Locations: 🇺🇸
The University of Kansas Cancer Center, Westwood, Kansas, United States

Ultra-hypofractionated Radiation in Prostate Cancer

Not Applicable

Active, not recruiting

Conditions: Early Stage Prostate Cancer

Interventions: Radiation: Hypofractionated Radiation

First Posted Date: 2018-04-03

Last Posted Date: 2023-04-06

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 13

Registration Number: NCT03486821

Locations: 🇺🇸
University of Kansas Medical Center/ Cancer Center, Kansas City, Kansas, United States

Aerobic Walking Exercise for Non-Ambulatory Stroke Survivors

Not Applicable

Conditions: Stroke

Interventions: Behavioral: Standard physical therapy
Behavioral: Aerobic walking program

First Posted Date: 2018-03-27

Last Posted Date: 2019-03-08

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 40

Registration Number: NCT03479632

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy